Experts Urge Older Adults’ Participation in Clinical Trials, Highlight Research Value
Experts from Aging Untold discuss what to look for when considering participation in clinical trials and emphasize the critical need for older adults to be included in research. They explain that trials are not a last resort but an opportunity…
Terre Haute, IN, October 30, 2026 — As advancements in medical research continue, experts are underscoring the vital role older adults play in clinical trials and advising on how to approach participation. A discussion from experts at Aging Untold highlighted the importance of including diverse age groups, particularly seniors, in research initiatives.
The experts emphasized that clinical trials should not be viewed as a last resort. Instead, they represent an opportunity for participants to potentially access innovative treatments before they are widely available. This perspective reframes trial participation as a proactive step toward personal health and contributing to future medical breakthroughs.
A key argument for greater inclusion of older adults in research is rooted in pharmacological differences. Medications can affect older individuals differently than younger populations due to changes in metabolism, organ function, and the presence of multiple health conditions. Including older adults in trials is therefore critical for understanding these specific effects and ensuring the safety and efficacy of new drugs and therapies for this demographic.
Key considerations for individuals contemplating participation include:
- Understanding the Scientific Question: Participants are encouraged to ascertain the primary research question the trial aims to answer. This provides context for the study’s goals.
- Locating Studies: Resources such as ClinicalTrials.gov were identified as valuable tools for individuals seeking information about ongoing clinical trials.
- Awareness of Trial Design: It is important for potential participants to understand various aspects of the trial, including the possibility of receiving a placebo.
The experts reiterated that older adults are essential to the development of future medicines. Their participation provides invaluable data that informs the creation of treatments that are both safe and effective for the aging population, ultimately contributing to improved public health outcomes.
Story summarized from the original created by LeAnne Gendreau, Katherine Ambrose , Sondra ‘Sam’ Cradduck , Amy Amy Cameron O’Rourke, Rhea Rogers on www.wthitv.com, see more information here.
Media gallery
